Study reveals a paradigm shift in the understanding of T-lineage acute lymphoblastic leukemia

FHS
August 15, 2024
12:43 am

Researchers at Children’s Hospital of Philadelphia (CHOP), St. Jude Children’s Research Hospital (St. Jude) and the Children’s Oncology Group (COG) today announced a significant paradigm shift in the understanding of T-lineage acute lymphoblastic leukemia (T-ALL), an aggressive and high-risk form of cancer, to one frequently driven by genetic changes in non-coding portions of our DNA.

Adaptimmune’s debt financing deal; Tenaya to cut workers

Plus, news about Brixton Biosciences, Merck KGaA, Medincell, CellProthera and GSK: Adaptimmune inks up to $125M debt financing: The biotech gets $25 million to start

May 16, 2024

Roche seeks to project confidence on its obesity drugs — and sees room to make its mark

LONDON — Roche executives on Monday argued that their experimental obesity medications would prove to have advantages over their rivals’ products — and that the

September 30, 2024

NYU Langone expands footprint with Rothman Orthopaedics acquisition

NYU Langone Health and NYU Langone Orthopedics today announced the acquisition of Rothman Orthopaedics of Greater New York, further expanding the system’s top-ranked offerings at

January 7, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.